Literature DB >> 20848543

Use of complementary and alternative medicine by patients with inflammatory bowel disease.

Robert J Hilsden1, Marja J Verhoef, Heidi Rasmussen, Antony Porcino, Jennifer C C DeBruyn.   

Abstract

In this review article we provide a broad overview of complementary and alternative medicine (CAM) use in inflammatory bowel diseases (IBDs), including prevalence of use, common therapies used, and reasons for and factors associated with CAM use. CAM is commonly used by those suffering from IBD. Multiple forms of CAM are used to treat IBD, and often patients use multiple CAM therapies and continue to use conventional medical therapies. Patients using CAM report benefits that extend beyond simply improved disease control. Using CAM allows patients to exert a greater degree of control over their disease and its management than they are afforded by conventional medicine. There is limited evidence on the efficacy of CAM therapies in IBD. It is important for physicians caring for those with IBD to be familiar with common forms of CAM and to be able to provide general counseling to their patients about CAM use.

Entities:  

Mesh:

Year:  2011        PMID: 20848543     DOI: 10.1002/ibd.21360

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  31 in total

Review 1.  Therapeutic potential of curcumin in digestive diseases.

Authors:  Pietro Dulbecco; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 2.  Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.

Authors:  Stefanie Joos
Journal:  Chin J Integr Med       Date:  2011-06-10       Impact factor: 1.978

3.  Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer?

Authors:  Christian Jobin
Journal:  Gut Microbes       Date:  2010-05-26

Review 4.  Mechanisms on spasmolytic and anti-inflammatory effects of a herbal medicinal product consisting of myrrh, chamomile flower, and coffee charcoal.

Authors:  Cica Vissiennon; Karl-Heinz Goos; Jürgen Arnhold; Karen Nieber
Journal:  Wien Med Wochenschr       Date:  2017-01-13

Review 5.  Autophagy: a new target or an old strategy for the treatment of Crohn's disease?

Authors:  Kris Nys; Patrizia Agostinis; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-16       Impact factor: 46.802

Review 6.  Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern.

Authors:  Haider Rahman; Marina Kim; Galen Leung; Jesse A Green; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

7.  Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD.

Authors:  Ying Song; David Dunkin; Stephanie Dahan; Alina Iuga; Clare Ceballos; Kathy Hoffstadter-Thal; Nan Yang; Keith Benkov; Lloyd Mayer; Xiu-Min Li
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

8.  Addressing the mind, body, and spirit in a gastrointestinal practice for inflammatory bowel disease patients.

Authors:  Sharon Jedel; Vered Hankin; Robin M Voigt; Ali Keshavarzian
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-13       Impact factor: 11.382

9.  Complementary and alternative medicine use by US adults with gastrointestinal conditions: Results from the 2012 National Health Interview Survey.

Authors:  Michelle L Dossett; Roger B Davis; Anthony J Lembo; Gloria Y Yeh
Journal:  Am J Gastroenterol       Date:  2014-07-08       Impact factor: 10.864

10.  Fatigue interference with daily living among patients with inflammatory bowel disease.

Authors:  Randi Opheim; May Solveig Fagermoen; Tomm Bernklev; Lars-Petter Jelsness-Jorgensen; Bjorn Moum
Journal:  Qual Life Res       Date:  2013-08-23       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.